Neurocrine Biosciences CEO Kevin Gorman's 2019 pay rises 9% to $9.5M
Neurocrine Biosciences reports 2019 executive compensation
By ExecPay News
Published: April 9, 2020
Neurocrine Biosciences reported fiscal year 2019 executive compensation information on April 9, 2020.
In 2019, six executives at Neurocrine Biosciences received on average a compensation package of $5.9M, a 15% increase compared to previous year.
Average pay of disclosed executives at Neurocrine Biosciences
Kevin C. Gorman, Chief Executive Officer, received $9.5M in total, which increased by 9% compared to 2018. 63% of Gorman's compensation, or $6M, was in option awards. Gorman also received $667K in bonus, $725K in salary, $2M in stock awards, as well as $58K in other compensation.
For fiscal year 2019, the median employee pay was $257,209 at Neurocrine Biosciences. Therefore, the ratio of Kevin C. Gorman's pay to the median employee pay was 37 to one.
Matthew C. Abernethy, Chief Financial Officer, received a compensation package of $5.8M, which increased by 117% compared to previous year. 64% of the compensation package, or $3.8M, was in option awards.
Eric Benevich, Chief Commercial Officer, earned $5.8M in 2019, a 58% increase compared to previous year.
Eiry W. Roberts, Chief Medical Officer, received $4.9M in 2019, which decreases by 41% compared to 2018.
Haig P. Bozigian, Chief Development Officer, earned $4.8M in 2019, a 60% increase compared to previous year.
Kyle W. Gano, Chief Development and Strategy Officer, received $4.7M in 2019, which increases by 3% compared to 2018.
Related executives
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
Matthew Abernethy
Neurocrine Biosciences
Chief Financial Officer
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
Kyle Gano
Neurocrine Biosciences
Chief Development and Strategy Officer
You may also like
Source: SEC filing on April 9, 2020.